Randomized Clinical Trial for the Prevention of Cognitive Impairment in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacodynamics
- Acronyms GIRAF
- 07 Jun 2017 Biomarkers information updated
- 24 Oct 2016 Planned End Date changed from 1 May 2017 to 1 May 2018.
- 24 Oct 2016 Planned primary completion date changed from 1 May 2016 to 1 Jun 2017.